All lobbying filings

AVENUE SOLUTIONS

Lobbying for MERCK & CO. INC. · developer, manufacturer and distributor of pharmaceuticals

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Jan 20, 2026

Official filing document

Lobbying activity 2

Health Issues

Issues related to vaccines; Expiring healthcare extenders

Medicare/Medicaid

Issues related to Medicare and Medicaid coverage and reimbursement; Issues related to cyclic peptides; Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to the implementation of the Inflation Reduction Act of 2022

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.